Saptak chem & business Limited has filed its quarterly compliance certificate with BSE Limited, fulfilling regulatory requirements under SEBI's depositories regulations for the quarter ended March 31, 2026.

Regulatory Compliance Filing

The company submitted the mandatory certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 on April 8, 2026. Director Jubin Premji Gada signed the submission letter addressed to BSE Limited, confirming the company's adherence to regulatory protocols.

Transfer Agent Confirmation

MCS Share Transfer Agent Limited, serving as the company's registrar and transfer agent, provided the required confirmation certificate dated April 7, 2026. The transfer agent confirmed that all securities received from depository participants for dematerialization during Q4 FY26 were properly processed according to regulatory standards.

The confirmation certificate validates that:

• Securities received for dematerialization were confirmed to depositories
• Security certificates were mutilated and cancelled after due verification
• Depository names were substituted in the register of members as registered owners within the mandated 15-day period
• All securities remain listed on stock exchanges where previously issued securities are traded

Corporate Information

Saptak Chem and Business Limited operates from its registered office located on the 6th Floor, B-Wing, B D Patel House, Naranpura, Ahmedabad. The company maintains its corporate website at www.saptakchem.com and holds CIN number L24299GJ1980PLC101976.

This quarterly filing demonstrates the company's commitment to maintaining compliance with SEBI's depositories regulations and ensuring proper handling of shareholder securities through authorized transfer agents.

Saptak Chem & Business Limited announced the successful allotment of 20,00,000 fully paid-up equity shares following the conversion of warrants by non-promoter investors. The Board of Directors approved this allotment during their meeting held on April 06, 2026, marking a significant capital expansion for the Ahmedabad-based company.

Board Meeting Outcome

The Board of Directors meeting commenced at 5:15 p.m. and concluded at 5:30 p.m. on April 06, 2026. The meeting was conducted in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Director Jubin Premji Gada (DIN: 10820579) signed the official outcome document.

Warrant Conversion Details

The allotment involved four non-promoter investors who exercised their right to convert share warrants into equity shares. Each investor converted 5,00,000 warrants, with the conversion completed upon payment of the remaining exercise price.

Financial Impact

The warrant conversion generated Rs.1,57,50,000 for the company through the collection of the remaining exercise price of Rs.7.875 per warrant. This amount represents 75% of the total warrant exercise price of Rs.10.50 per warrant, with the initial 25% having been paid during the original warrant allotment on January 13, 2026.

Capital Structure Changes

The allotment significantly expanded the company's equity base, with the paid-up capital increasing substantially following the warrant conversion.

Outstanding Warrants Status

Following this conversion, the company maintains a substantial number of outstanding warrants available for future conversion.

The remaining 20,00,000 warrants can be converted into an equal number of equity shares by paying Rs.7.875 per warrant within 18 months from the original allotment date of January 13, 2026. The newly allotted equity shares rank pari passu with existing equity shares in all respects, providing equal rights and privileges to the new shareholders.